We are live on ! Find out more
TCOV

Trust Company of Vermont Portfolio holdings

AUM $2.68B
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$42.5M
Cap. Flow
+$2.61M
Cap. Flow %
0.22%
Top 10 Hldgs %
19.99%
Holding
1,087
New
93
Increased
215
Reduced
205
Closed
49

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.6M
2
BND icon
Vanguard Total Bond Market
BND
+$1.2M
3
MSM icon
MSC Industrial Direct
MSM
+$832K
4
AMAT icon
Applied Materials
AMAT
+$793K
5
JPM icon
JPMorgan Chase
JPM
+$775K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.18M
2
DD icon
DuPont de Nemours
DD
+$810K
3
FDX icon
FedEx
FDX
+$681K
4
XOM icon
ExxonMobil
XOM
+$545K
5
WFC icon
Wells Fargo
WFC
+$517K

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 13.27%
3 Healthcare 13.2%
4 Industrials 11.18%
5 Consumer Staples 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VZ icon
26
Verizon
VZ
$196B
$13M 1.08%
227,939
+3,361
+1% +$194K
HON icon
27
Honeywell
HON
$72.9B
$12.9M 1.07%
78,339
+1,569
+2% +$250K
APD icon
28
Air Products & Chemicals
APD
$68.9B
$12.9M 1.07%
56,881
-379
-0.7% -$78.5K
HD icon
29
Home Depot
HD
$353B
$12.8M 1.06%
61,375
+845
+1% +$169K
NEE icon
30
NextEra Energy
NEE
$179B
$12.6M 1.05%
246,688
-64
-0% -$3.15K
ECL icon
31
Ecolab
ECL
$79.8B
$12.2M 1.02%
62,003
+490
+0.8% +$91.1K
CVX icon
32
Chevron
CVX
$386B
$12M 1%
96,638
+1,777
+2% +$215K
PFE icon
33
Pfizer
PFE
$152B
$11.8M 0.98%
288,107
+1,375
+0.5% +$54.6K
TMO icon
34
Thermo Fisher Scientific
TMO
$224B
$11.8M 0.98%
40,092
-637
-2% -$175K
SBUX icon
35
Starbucks
SBUX
$122B
$11.6M 0.96%
138,239
-752
-0.5% -$59K
MCD icon
36
McDonald's
MCD
$194B
$11.5M 0.96%
55,430
-70
-0.1% -$13.9K
COST icon
37
Costco
COST
$419B
$11.4M 0.95%
43,308
+808
+2% +$201K
ADP icon
38
Automatic Data Processing
ADP
$108B
$11M 0.91%
66,349
-1,281
-2% -$208K
INTC icon
39
Intel
INTC
$493B
$10.9M 0.9%
226,953
-1,413
-0.6% -$70.1K
NVS icon
40
Novartis
NVS
$294B
$10.2M 0.85%
111,995
-13,885
-11% -$1.18M
DEO icon
41
Diageo
DEO
$52.8B
$10.2M 0.85%
59,093
-41
-0.1% -$6.89K
NKE icon
42
Nike
NKE
$61.3B
$10.1M 0.84%
120,706
-536
-0.4% -$45.1K
NSC icon
43
Norfolk Southern
NSC
$75.2B
$10M 0.83%
50,288
-1,155
-2% -$229K
AMT icon
44
American Tower
AMT
$79B
$9.8M 0.81%
47,930
+1,010
+2% +$203K
ITW icon
45
Illinois Tool Works
ITW
$83.5B
$9.66M 0.8%
64,039
-663
-1% -$100K
BKNG icon
46
Booking.com
BKNG
$160B
$9.62M 0.8%
128,225
+4,450
+4% +$320K
LOW icon
47
Lowe's Companies
LOW
$124B
$9.49M 0.79%
94,044
+999
+1% +$105K
VWO icon
48
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$9.39M 0.78%
220,690
-6,674
-3% -$281K
O icon
49
Realty Income
O
$58.6B
$8.73M 0.72%
130,659
-547
-0.4% -$37.4K
CME icon
50
CME Group
CME
$93.2B
$8.59M 0.71%
44,243
+63
+0.1% +$11.6K
1
2
3 4 5

Similar funds

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
HC
Henshaw Capital Woburn, Massachusetts $2.7B AUM 29.67% 1-Year Est. Return
CI
Capital International Los Angeles, California $2.7B AUM 31.08% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Trust Company of Vermont's Q2 2019 Portfolio in Review

As of Q2 2019, Trust Company of Vermont held 1,087 positions worth $1.2B, up 3.7% from $1.16B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trust Company of Vermont's Q2 2019 filing shows 93 new, 215 increased, 205 reduced and 49 closed positions. Its largest new stake was Dow Inc: 12,586 shares worth $620K. The largest sale was Novartis, an estimated $1.18M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Trust Company of Vermont's largest Q2 2019 buy was Dow Inc: 12,586 shares worth $620K.
  • Trust Company of Vermont added most to CVS Health in Q2 2019, an estimated $1.6M increase.
  • Trust Company of Vermont's biggest Q2 2019 reduction was Novartis, cutting an estimated $1.18M.
  • Trust Company of Vermont fully exited Bemis in Q2 2019, selling an estimated $353K.
  • Trust Company of Vermont's ten largest holdings make up 20% of its $1.2B portfolio in Q2 2019.
  • Trust Company of Vermont opened 93 new positions and closed 49 in Q2 2019.
  • Trust Company of Vermont's portfolio value rose 3.7% quarter-over-quarter to $1.2B.

Based on Trust Company of Vermont's 13F filing for Q2 2019, filed 26 Jul 2019.